Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

Brian Lian

CEO, President at Viking Therapeutics, Inc. (VKTX)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $14.0M

Reported trades

Filed Stock Type Shares Price Value Since
Jul 29SEC VKTXViking Therapeutics, Inc. Sell 148,5172,572,441 held (−5%) $33.32 $4.9M -14.4%
Jan 5SEC VKTXViking Therapeutics, Inc. Sell 132,4542,600,246 held (−5%) $32.29 $4.3M -11.7%
Jan 5SEC VKTXViking Therapeutics, Inc. Sell 53,2792,546,967 held (−2%) $33.38 $1.8M -14.6%
Jan 5SEC VKTXViking Therapeutics, Inc. Sell 41,2762,505,691 held (−2%) $34.22 $1.4M -16.7%
Jan 5SEC VKTXViking Therapeutics, Inc. Sell 6,4002,499,291 held (−0%) $35.07 $224K -18.7%
Oct 28SEC VKTXViking Therapeutics, Inc. Sell 38,9892,419,109 held (−2%) $35.01 $1.4M -18.6%